Literature DB >> 20009062

Late-life dementias: does this unyielding global challenge require a broader view?

Thomas J Montine, Eric B Larson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20009062      PMCID： PMC2827770          DOI： 10.1001/jama.2009.1863

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Central obesity and increased risk of dementia more than three decades later.

Authors:  Nikolaos Tezapsidis; Mark A Smith; J Wes Ashford
Journal:  Neurology       Date:  2009-03-17       Impact factor: 9.910

2.  Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older.

Authors:  Eric B Larson; Li Wang; James D Bowen; Wayne C McCormick; Linda Teri; Paul Crane; Walter Kukull
Journal:  Ann Intern Med       Date:  2006-01-17       Impact factor: 25.391

3.  Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project.

Authors:  A B Graves; E B Larson; S D Edland; J D Bowen; W C McCormick; S M McCurry; M M Rice; A Wenzlow; J M Uomoto
Journal:  Am J Epidemiol       Date:  1996-10-15       Impact factor: 4.897

4.  Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

Authors:  G Li; R Higdon; W A Kukull; E Peskind; K Van Valen Moore; D Tsuang; G van Belle; W McCormick; J D Bowen; L Teri; G D Schellenberg; E B Larson
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

5.  Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.

Authors:  Wolfgang Lieb; Alexa S Beiser; Ramachandran S Vasan; Zaldy S Tan; Rhoda Au; Tamara B Harris; Ronenn Roubenoff; Sanford Auerbach; Charles DeCarli; Philip A Wolf; Sudha Seshadri
Journal:  JAMA       Date:  2009-12-16       Impact factor: 56.272

Review 6.  Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.

Authors:  Dennis J Selkoe
Journal:  Behav Brain Res       Date:  2008-02-17       Impact factor: 3.332

7.  Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial.

Authors:  Nicola T Lautenschlager; Kay L Cox; Leon Flicker; Jonathan K Foster; Frank M van Bockxmeer; Jianguo Xiao; Kathryn R Greenop; Osvaldo P Almeida
Journal:  JAMA       Date:  2008-09-03       Impact factor: 56.272

8.  Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study.

Authors:  Ge Li; Isaac C Rhew; Jane B Shofer; Walter A Kukull; John C S Breitner; Elaine Peskind; James D Bowen; Wayne McCormick; Linda Teri; Paul K Crane; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2007-08       Impact factor: 5.562

Review 9.  Gamma-secretase inhibition and modulation for Alzheimer's disease.

Authors:  Michael S Wolfe
Journal:  Curr Alzheimer Res       Date:  2008-04       Impact factor: 3.498

Review 10.  Ageing populations: the challenges ahead.

Authors:  Kaare Christensen; Gabriele Doblhammer; Roland Rau; James W Vaupel
Journal:  Lancet       Date:  2009-10-03       Impact factor: 79.321
View more
  12 in total

1.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.

Authors:  Bradley T Hyman; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Maria C Carrillo; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; Bill Thies; John Q Trojanowski; Harry V Vinters; Thomas J Montine
Journal:  Alzheimers Dement       Date:  2012-01       Impact factor: 21.566

Review 2.  Prospects for delaying the rising tide of worldwide, late-life dementias.

Authors:  Eric B Larson
Journal:  Int Psychogeriatr       Date:  2010-07-01       Impact factor: 3.878

3.  Leveraging neuropathological data in pharmacoepidemiology: A promising approach for dementia prevention?

Authors:  Zachary A Marcum; C Dirk Keene; Eric B Larson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-06-29       Impact factor: 2.890

4.  Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults.

Authors:  Lori B Daniels; Gail A Laughlin; Donna Kritz-Silverstein; Paul Clopton; Wei-Chung Chen; Alan S Maisel; Elizabeth Barrett-Connor
Journal:  Am J Med       Date:  2011-07       Impact factor: 4.965

5.  Histamine-2 receptor antagonist use and incident dementia in an older cohort.

Authors:  Shelly L Gray; Rod Walker; Sascha Dublin; Sebastien Haneuse; Paul K Crane; John C S Breitner; James Bowen; Wayne McCormick; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2011-02       Impact factor: 5.562

6.  Ecology of the aging human brain.

Authors:  Joshua A Sonnen; Karen Santa Cruz; Laura S Hemmy; Randall Woltjer; James B Leverenz; Kathleen S Montine; Clifford R Jack; Jeffrey Kaye; Kelvin Lim; Eric B Larson; Lon White; Thomas J Montine
Journal:  Arch Neurol       Date:  2011-08

Review 7.  Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.

Authors:  Luis F Gonzalez-Cuyar; Joshua A Sonnen; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

Review 8.  Anatomic and clinical pathology of cognitive impairment and dementia.

Authors:  Kathleen S Montine; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 9.  The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).

Authors:  Adam L Boxer; Michael Gold; Edward Huey; William T Hu; Howard Rosen; Joel Kramer; Fen-Biao Gao; Edward A Burton; Tiffany Chow; Aimee Kao; Blair R Leavitt; Bruce Lamb; Megan Grether; David Knopman; Nigel J Cairns; Ian R Mackenzie; Laura Mitic; Erik D Roberson; Daniel Van Kammen; Marc Cantillon; Kathleen Zahs; George Jackson; Stephen Salloway; John Morris; Gary Tong; Howard Feldman; Howard Fillit; Susan Dickinson; Zaven S Khachaturian; Margaret Sutherland; Susan Abushakra; Joseph Lewcock; Robert Farese; Robert O Kenet; Frank Laferla; Steve Perrin; Steve Whitaker; Lawrence Honig; Marsel M Mesulam; Brad Boeve; Murray Grossman; Bruce L Miller; Jeffrey L Cummings
Journal:  Alzheimers Dement       Date:  2012-10-10       Impact factor: 21.566

10.  Somatic comorbidities and Alzheimer's disease treatment.

Authors:  Alessandra Clodomiro; Pietro Gareri; Gianfranco Puccio; Francesca Frangipane; Roberto Lacava; Alberto Castagna; Valeria Graziella Laura Manfredi; Rosanna Colao; Amalia Cecilia Bruni
Journal:  Neurol Sci       Date:  2013-02-01       Impact factor: 3.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.